These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3894277)

  • 1. A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
    Cowan JD; Osborne CK; Neidhart JA; Von Hoff DD; Constanzi JJ; Vaughn CB
    Invest New Drugs; 1985; 3(2):149-52. PubMed ID: 3894277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study.
    Cowan JD; Neidhart J; McClure S; Coltman CA; Gumbart C; Martino S; Hutchins LF; Stephens RL; Vaughan CB; Osborne CK
    J Natl Cancer Inst; 1991 Aug; 83(15):1077-84. PubMed ID: 1875415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer.
    Allegra JC; Woodcock T; Woolf S; Henderson IC; Bryan S; Reisman A; Dukart G
    Invest New Drugs; 1985; 3(2):153-61. PubMed ID: 3894278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
    Bennett JM; Byrne P; Desai A; White C; DeConti R; Vogel C; Krementz E; Muggia F; Doroshow J; Plotkin D
    Invest New Drugs; 1985; 3(2):179-85. PubMed ID: 3894279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.
    Metz R; Delgado M; Keiling R; Cappelaere P; Armand JP; Prevot G; Misset JL; Grimbert J; Mathe G
    Invest New Drugs; 1985; 3(2):163-6. PubMed ID: 4019119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
    De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.
    Mouridsen HT; Cornbleet M; Stuart-Harris R; Smith I; Coleman R; Rubens R; McDonald M; Rainer H; van Oosterom A; Smyth J
    Invest New Drugs; 1985; 3(2):139-48. PubMed ID: 4019118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mitoxantrone and doxorubicin in breast cancer.
    Neidhart JA; Gochnour D; Roach R; Hoth D; Young D
    J Clin Oncol; 1986 May; 4(5):672-7. PubMed ID: 3517241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
    Henderson IC; Allegra JC; Woodcock T; Wolff S; Bryan S; Cartwright K; Dukart G; Henry D
    J Clin Oncol; 1989 May; 7(5):560-71. PubMed ID: 2468745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative trial of mitoxantrone and doxorubicin in patients with minimally pretreated breast cancer.
    Neidhart JA; Gochnour D; Roach RW; Young D; Steinberg JA
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):11-4. PubMed ID: 6385259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.
    Neidhart JA; Gochnour D; Roach RW; Steinberg JA; Young D
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():41-6. PubMed ID: 6362877
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer.
    Holmes FA; Yap HY; Esparza L; Buzdar AU; Hortobagyi GN; Blumenschein GR
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):28-31. PubMed ID: 6385262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients.
    Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT; Smyth JF
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1141-6. PubMed ID: 6541135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer.
    Periti P; della Cuna GR; Pannuti F; Mazzei T; Preti P; Martoni A; Mini E
    Invest New Drugs; 1985; 3(2):167-71. PubMed ID: 4019120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicity.
    Coleman RE; Maisey MN; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1984 Jun; 20(6):771-6. PubMed ID: 6540179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisantrene, an active drug in patients with advanced breast cancer.
    Osborne CK; Von Hoff DD; Cowan JD; Sandbach J
    Cancer Treat Rep; 1984 Feb; 68(2):357-60. PubMed ID: 6697324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of a combination of doxorubicin and mitoxantrone in metastatic breast cancer.
    Ford JM; Panasci L; Leclerc Y; Margolese R
    Cancer Treat Rep; 1987 Oct; 71(10):921-5. PubMed ID: 3308079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1669-74. PubMed ID: 6591857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicity.
    Perren TJ; Blackledge G; Mould JJ; Chetiyawardana AD; Morrison M; Hancock A
    Invest New Drugs; 1985; 3(2):173-7. PubMed ID: 3926713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone as a first-line treatment of advanced breast cancer.
    Landys K; Borgstrom S; Andersson T; Noppa H
    Invest New Drugs; 1985; 3(2):133-7. PubMed ID: 4019117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.